Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1956 1
1957 1
1958 1
1959 1
1973 1
1978 1
1986 1
1990 1
1991 3
1996 1
1997 1
2000 1
2001 2
2007 1
2010 4
2011 2
2013 1
2014 1
2015 1
2017 2
2020 2
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for levothyroxine am pharm
Your search for levothyroxine-amdipharm retrieved no results
Iodine allergy: Common misperceptions.
Wulf NR, Schmitz J, Choi A, Kapusnik-Uner J. Wulf NR, et al. Am J Health Syst Pharm. 2021 Apr 22;78(9):781-793. doi: 10.1093/ajhp/zxab033. Am J Health Syst Pharm. 2021. PMID: 33547463 Free PMC article. Review.
SUMMARY: Iodine is an essential human nutrient found in the thyroid gland. It is used in the synthesis of the thyroid hormones thyroxine and triiodothyroxine. Patients who report having adverse reactions to iodine-containing substances are often labelled as having an "iodi …
SUMMARY: Iodine is an essential human nutrient found in the thyroid gland. It is used in the synthesis of the thyroid hormones thyroxine …
Alternative schedules of levothyroxine administration.
Geer M, Potter DM, Ulrich H. Geer M, et al. Am J Health Syst Pharm. 2015 Mar 1;72(5):373-7. doi: 10.2146/ajhp140250. Am J Health Syst Pharm. 2015. PMID: 25694412 Review.
PURPOSE: Published evidence on bedtime versus prebreakfast administration of levothyroxine is reviewed. SUMMARY: Because levothyroxine absorption has been shown to increase when the drug is administered to patients in a fasted state, the standard recommendation is t …
PURPOSE: Published evidence on bedtime versus prebreakfast administration of levothyroxine is reviewed. SUMMARY: Because levothyro …
Rivastigmine-induced dystonia.
Pavlis CJ, Kutscher EC, Carnahan RM, Kennedy WK, Van Gerpen S, Schlenker E. Pavlis CJ, et al. Am J Health Syst Pharm. 2007 Dec 1;64(23):2468-70. doi: 10.2146/ajhp060399. Am J Health Syst Pharm. 2007. PMID: 18029952
During the current hospitalization, she was taking clonazepam, dextroamphetamine, lamotrigine, lansoprazole, levothyroxine, memantine, quetiapine, risperidone, rivastigmine, tranylcypromine, trazodone, and zolpidem. ...
During the current hospitalization, she was taking clonazepam, dextroamphetamine, lamotrigine, lansoprazole, levothyroxine, memantine …
Probable interaction between levothyroxine and ritonavir: Case report and literature review.
Sahajpal R, Ahmed RA, Hughes CA, Foisy MM. Sahajpal R, et al. Am J Health Syst Pharm. 2017 Apr 15;74(8):587-592. doi: 10.2146/ajhp160200. Am J Health Syst Pharm. 2017. PMID: 28389458 Review.
An interaction between ritonavir and levothyroxine was suspected, and dolutegravir was substituted for lopinavir-ritonavir. ...Scoring of the case using the Drug Interaction Probability Scale yielded a score of 6 out of 11, indicating a probable interaction between levo …
An interaction between ritonavir and levothyroxine was suspected, and dolutegravir was substituted for lopinavir-ritonavir. ...Scorin …
Drug absorption in celiac disease.
Tran TH, Smith C, Mangione RA. Tran TH, et al. Am J Health Syst Pharm. 2013 Dec 15;70(24):2199-206. doi: 10.2146/ajhp120689. Am J Health Syst Pharm. 2013. PMID: 24296842 Review.
A small number of published studies suggest that celiac disease may be associated with altered drug absorption, resulting in higher serum concentrations of propranolol, lower peak concentrations of acetaminophen and practolol, higher dosing requirements with levothyroxine, …
A small number of published studies suggest that celiac disease may be associated with altered drug absorption, resulting in higher serum co …
Intravenous levothyroxine stewardship program at a tertiary academic medical center.
Marino KK, Crowley KE, Tran LK, Sylvia D, Dell'Orfano H, DeGrado JR, Szumita PM. Marino KK, et al. Am J Health Syst Pharm. 2021 Jun 23;78(13):1200-1206. doi: 10.1093/ajhp/zxab155. Am J Health Syst Pharm. 2021. PMID: 33821921
PURPOSE: Based on the pharmacokinetic profile of levothyroxine, a 3-day hold guideline for adult patients ordered for intravenous (IV) levothyroxine was implemented at a tertiary academic medical center. ...To our knowledge, this is the first published report of an …
PURPOSE: Based on the pharmacokinetic profile of levothyroxine, a 3-day hold guideline for adult patients ordered for intravenous (IV …
Stability and consistency of compounded oral liquid levothyroxine formulations.
Meyer LM, Stephens K, Carter CA, Pickard W, Johnson PR, Eagerton DH. Meyer LM, et al. J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):e168-e172. doi: 10.1016/j.japh.2020.05.014. Epub 2020 Jun 24. J Am Pharm Assoc (2003). 2020. PMID: 32591200 Free article.
OBJECTIVE: With consideration of the narrow therapeutic index of levothyroxine (LT4), the objective of this study was to investigate the stability and consistency of compounded oral liquid formulations of LT4. ...
OBJECTIVE: With consideration of the narrow therapeutic index of levothyroxine (LT4), the objective of this study was to investigate …
Concomitant use of levothyroxine and interacting medications in U.S. ambulatory care visits.
Dempsey AL, Wang GH, Singh Ospina N, Vouri SM. Dempsey AL, et al. J Am Pharm Assoc (2003). 2023 Sep-Oct;63(5):1553-1557.e3. doi: 10.1016/j.japh.2023.06.008. Epub 2023 Jun 15. J Am Pharm Assoc (2003). 2023. PMID: 37329957
BACKGROUND: Levothyroxine (LT4) is the third most commonly prescribed medication in the United States. ...
BACKGROUND: Levothyroxine (LT4) is the third most commonly prescribed medication in the United States. ...
Rhabdomyolysis associated with phentermine.
Steidl KE, Darko W, Probst LA, Noviasky JA, Nasser S. Steidl KE, et al. Am J Health Syst Pharm. 2010 Nov 15;67(22):1929-32. doi: 10.2146/ajhp090395. Am J Health Syst Pharm. 2010. PMID: 21048209
The patient's home medications included the following, administered orally: esomeprazole, levothyroxine, irbesartan- hydrochlorothiazide, metoprolol succinate, metoclopramide, dicyclomine, oxycodone-acetaminophen, and oxycodone extended-release. ...
The patient's home medications included the following, administered orally: esomeprazole, levothyroxine, irbesartan- hydrochlorothiaz …
Drug therapy reviews: management of hypothyroidism.
Cobb WE, Jackson IM. Cobb WE, et al. Am J Hosp Pharm. 1978 Jan;35(1):51-8. Am J Hosp Pharm. 1978. PMID: 341699 Review.
The therapeutic use of the following thyroid agents is reviewed: levothyroxine sodium, Thyroid USP, thyroglobulin, liotrix, and liothyronine sodium. Myxedema coma, neonatal hypothyroidism, primary hypothyroidism, and secondary and tertiary hypothyroidism are specific hypot …
The therapeutic use of the following thyroid agents is reviewed: levothyroxine sodium, Thyroid USP, thyroglobulin, liotrix, and lioth …
34 results